Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease

BACKGROUND: The previously described and validated Erlangen Score (ES) algorithm enables interpretation of the cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD), ordering them on an ordinal scale: from neurochemically normal (ES = 0) through improbable AD (ES = 1), possible AD (ES = 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldeiras, Inês, Santana, Isabel, Leitão, Maria João, Vieira, Daniela, Duro, Diana, Mroczko, Barbara, Kornhuber, Johannes, Lewczuk, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320577/
https://www.ncbi.nlm.nih.gov/pubmed/30611311
http://dx.doi.org/10.1186/s13195-018-0456-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320577/
https://www.ncbi.nlm.nih.gov/pubmed/30611311
http://dx.doi.org/10.1186/s13195-018-0456-x

Ejemplares similares